Home Cart Sign in  
Chemical Structure| 6402-23-9 Chemical Structure| 6402-23-9

Structure of Acrinol Monohydrate
CAS No.: 6402-23-9

Chemical Structure| 6402-23-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Acrinol Monohydrate is an aromatic organic compound based on acridine, primary used as an antiseptic against mostly Gram-positive bacteria.

Synonyms: Ethacridine lactate monohydrate; Acrinol monohydrat; Ethodin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Acrinol Monohydrate

CAS No. :6402-23-9
Formula : C18H23N3O5
M.W : 361.39
SMILES Code : NC1=CC2=NC3=CC=C(OCC)C=C3C(N)=C2C=C1.CC(O)C(O)=O.[H]O[H]
Synonyms :
Ethacridine lactate monohydrate; Acrinol monohydrat; Ethodin
MDL No. :MFCD00149646
InChI Key :NYEPHMYJRNWPLA-UHFFFAOYSA-N
Pubchem ID :165457

Safety of Acrinol Monohydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
OCI-AML2 cells 15.6μM 72 h Evaluate erlotinib sensitivity in OCI-AML2 cells, showing an IC50 of 15.61 mM Haematologica. 2016 Nov;101(11):e449-e453
TEX cells 8.99 μM 72 h Evaluate erlotinib sensitivity in TEX cells, showing an IC50 of 8.99 mM Haematologica. 2016 Nov;101(11):e449-e453

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SCID mice OCI-AML2 subcutaneous injection model Intraperitoneal injection 20 mg/kg Once daily, 5 times per week for two weeks Evaluate the effect of erlotinib and ethacridine combination therapy on tumor growth, showing significant reduction in tumor growth Haematologica. 2016 Nov;101(11):e449-e453

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.84mL

2.77mL

1.38mL

27.67mL

5.53mL

2.77mL

References

 

Historical Records

Categories